Regenerative medicine for heart disease

Masayoshi Kinoshita, Keiichi Fukuda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Recent studies revealed that cardiomyocytes can be regenerated from both embryonic- and adult bone marrow-stem cells in animal experiment. Regenerated cardiomyocytes had fetal ventricular phenotype, expressed alpha 1, beta 1, and beta 2-adrenergic, and M2 cholinergic receptors, and revealed spontaneous beating. These cells could be transplanted into the recipient heart, and survive for long period. Clinical application of these cells had some problems at present. Embryonic stem cells had ethical problems, and had a possibility of making teratoma when undifferentiated cells could not be eliminated. Adult stem cells had a difficulty in isolation and culture expansion, since they were not yet well characterized. However, transplantation of regenerated cardiomyocytes would become a future method for the treatment of severe heart failure.

Original languageEnglish
Pages (from-to)480-484
Number of pages5
JournalNippon rinsho. Japanese journal of clinical medicine
Volume61
Issue number3
Publication statusPublished - 2003

Fingerprint

Regenerative Medicine
Cardiac Myocytes
Heart Diseases
Adult Stem Cells
Teratoma
Cholinergic Receptors
Embryonic Stem Cells
Bone Marrow Cells
Adrenergic Agents
Stem Cells
Heart Failure
Transplantation
Phenotype

Cite this

Regenerative medicine for heart disease. / Kinoshita, Masayoshi; Fukuda, Keiichi.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 61, No. 3, 2003, p. 480-484.

Research output: Contribution to journalArticle

@article{1c583569738c428c90f5c3014f8d561e,
title = "Regenerative medicine for heart disease",
abstract = "Recent studies revealed that cardiomyocytes can be regenerated from both embryonic- and adult bone marrow-stem cells in animal experiment. Regenerated cardiomyocytes had fetal ventricular phenotype, expressed alpha 1, beta 1, and beta 2-adrenergic, and M2 cholinergic receptors, and revealed spontaneous beating. These cells could be transplanted into the recipient heart, and survive for long period. Clinical application of these cells had some problems at present. Embryonic stem cells had ethical problems, and had a possibility of making teratoma when undifferentiated cells could not be eliminated. Adult stem cells had a difficulty in isolation and culture expansion, since they were not yet well characterized. However, transplantation of regenerated cardiomyocytes would become a future method for the treatment of severe heart failure.",
author = "Masayoshi Kinoshita and Keiichi Fukuda",
year = "2003",
language = "English",
volume = "61",
pages = "480--484",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "3",

}

TY - JOUR

T1 - Regenerative medicine for heart disease

AU - Kinoshita, Masayoshi

AU - Fukuda, Keiichi

PY - 2003

Y1 - 2003

N2 - Recent studies revealed that cardiomyocytes can be regenerated from both embryonic- and adult bone marrow-stem cells in animal experiment. Regenerated cardiomyocytes had fetal ventricular phenotype, expressed alpha 1, beta 1, and beta 2-adrenergic, and M2 cholinergic receptors, and revealed spontaneous beating. These cells could be transplanted into the recipient heart, and survive for long period. Clinical application of these cells had some problems at present. Embryonic stem cells had ethical problems, and had a possibility of making teratoma when undifferentiated cells could not be eliminated. Adult stem cells had a difficulty in isolation and culture expansion, since they were not yet well characterized. However, transplantation of regenerated cardiomyocytes would become a future method for the treatment of severe heart failure.

AB - Recent studies revealed that cardiomyocytes can be regenerated from both embryonic- and adult bone marrow-stem cells in animal experiment. Regenerated cardiomyocytes had fetal ventricular phenotype, expressed alpha 1, beta 1, and beta 2-adrenergic, and M2 cholinergic receptors, and revealed spontaneous beating. These cells could be transplanted into the recipient heart, and survive for long period. Clinical application of these cells had some problems at present. Embryonic stem cells had ethical problems, and had a possibility of making teratoma when undifferentiated cells could not be eliminated. Adult stem cells had a difficulty in isolation and culture expansion, since they were not yet well characterized. However, transplantation of regenerated cardiomyocytes would become a future method for the treatment of severe heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0037984778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037984778&partnerID=8YFLogxK

M3 - Article

C2 - 12701177

AN - SCOPUS:0037984778

VL - 61

SP - 480

EP - 484

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 3

ER -